[2,2'-Bipyridine]-6,6'-dicarboxylic acid, 95.0%, 250mg

piperazin-1-yl(4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-2-yl)methanone 2,2,2-trifluoroacetate, 95.0%, 500mg

Set di polarizzazione. L'analizzatore viene posizionato sull'oculare, il polarizzatore da 32 mm di diametro è posizionato nel portafiltro

N-(2-{[(1S,2R)-2-hydroxy-1,2-diphenylethyl]amino}-3,4-dioxocyclobut-1-en-1-yl)-2-methylpropane-2-sulfinamide, 95.52%, 100mg

1-(1H-benzimidazol-2-yl)-2-chloroethanone, 95.0%, 1g

5-(Bromomethyl)-1-methyl-4-nitro-1H-imidazole, 97%, 5g

2-Methyl-3-propylpyrazine>95.0%(GC)25mL

4-Methyl-1h-imidazole-5-carbonitrile, 95+%, 100mg

2-Bromonaphthalene, 99.0%, 100g

tert-butyl 3-(piperidin-4-yloxy)pyrrolidine-1-carboxylate, 95.0%, 1g

1,2-Dichlorobutane>96.0%(GC)5g

4-(Bromomethyl)benzo[d][1,3]dioxole, 95.0%, 1g

2-Isobutoxy-4-(trifluoromethyl)phenylboronic acid, 97%, 250mg